Four months into the construction of the first phase of its Kilroy Oyster Point development in South San Francisco, Calif., Kilroy Realty Corp. has signed its first lease—representing 35 percent of the $600 million project. Biopharmaceutical company Cytokinetics will take approximately 235,000 square feet in office and laboratory space beginning September 2021, when the building is expected to be completed. Gregg Domanico of Kidder Mathews represented the tenant.
For the full story, go to Commercial Property Executive.
© 2019 Commercial Property Executive. All rights reserved.